Oral administration of docosahexaenoic acid activates the GDNF-MAPK-CERB pathway in hippocampus of natural aged rat

Pharmaceutical Biology

Volumn 51, Issue 9, 2013, Pages 1188-1195

  Jiang, Li He ^a   Yan, Shi ^b   Wang, Jin ^a   Liang, Qiu Yun ^c  

^a GUANGXI UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Glial cell line derived neurotrophic factor; Lipid peroxidation; Mitogen activated protein kinase signaling pathway

Indexed keywords

CATALASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOCOSAHEXAENOIC ACID; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA 1; GLUTATHIONE PEROXIDASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN RET; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; LIPID COMPOSITION; LIPID PEROXIDATION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HIPPOCAMPUS; LIPID PEROXIDATION; MAP KINASE SIGNALING SYSTEM; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOREDUCTASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84882353036     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.784341     Document Type: Article

References (39)

1. Acsády L, Pascual M, Rocamora N, et al. (2000). Nerve growth factor but not neurotrophin-3 is synthesized by hippocampal GABAergic neurons that project to the medial septum. J Neurosci 98: 23-31.
2. Airaksinen MS, Saarma M. (2002). The GDNF family: Signaling, biological functions and therapeutic value. Nat Rev Neurosci 3: 383-94.
3. Bligh EG, Dyer W. (1959). A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-17.
4. Catalan J, Moriguchi T, Slotnick B, et al. (2002). Cognitive deficits in docosahexaenoic acid-deficient rats. Behav Neurosci 116: 1022-31.
5. Chao CC, Lee EH. (1999). Neuroprotective mechanism of glial cell linederived neurotrophic factor on dopamine neurons: Role of antioxidation. Neuropharmacology 38: 913-16.
6. Ciccarelli R, Ballerini P, Sabatino G, et al. (2001). Involvement of astrocytes in purine-mediated reparative processes in the brain. Int J Dev Neurosci 19: 395-414.
7. Creedon DJ, Tansey MG, Baloh RH, et al. (1997). Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons. Proc Natl Acad Sci USA 94: 7018-23.
8. Fischer W, Wictorin K, Björklund A, et al. (1987). Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329: 65-8.
9. Gash DM, Zhang Z, Ovadia A, et al. (1996). Functional recovery in GDNF treated Parkinsonian monkeys. Nature 380: 252-5.
10. Gong L, Wyatt RJ, Baker I, Masserano JMB. (1999). Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death. Neurosci Lett 263: 153-6.
11. Grondin R, Cass WA, Zhang Z, et al. (2003). Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys. J Neurosci 23: 1974-80.
12. Hebert MA, Gerhardt GA. (1997). Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J Pharmacol Exp Ther 282: 760-8.
13. Hossain MS, Hashimoto M, Gamoh S, Masumura S. (1999). Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats. J Neurochem 72: 1133-8.
14. Innis SM. (2000). The role of dietary n-6 and n-3 fatty acids in the developing brain. Dev Neurosci 22: 474-80.
15. Jiang LH, Shi Y, Wang LS, Yang ZH. (2009a). The influence of orally administered docosahexaenoic acid on cognitive ability in aged mice. J Nutr Biochem 20: 735-41.
16. Jiang LH, Yan S, Long Y, Yang ZR. (2009b). The influence of orally administered docosahexaenoic acid on monoamine neurotransmitter, nerve growth factor and brain-derived neurotrophic factor in aged mice. Pharm Biol 47: 584-91.
17. Jiang LH, Liang QY, Shi Y. (2012). Pure docosahexaenoic acid can improve depression behaviors and affect HPA axis in mice. Eur Rev Med Pharmacol Sci 16: 1765-73.
18. Jing S, Wen D, Yu Y, et al. (1996). GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85: 1113-24.
19. Kawashima A, Harada T, Kami H, et al. (2010). Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells. J Nutr Biochem 21: 268-77.
20. Kiray M, Uysal N, Sönmez A, et al. (2004). Positive effects of deprenyl and estradiol on spatial memory and oxidant stress in aged female rat brains. Neurosci Lett 354: 225-8.
21. Kirik D, Georgievska B, Björklund A. (2004). Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat Neurosci 7: 105-10.
22. Lim SY, Suzuki H. (2002). Dose-response effect of docosahexaenoic acid ethyl ester on maze behavior and brain fatty acid composition in adult mice. Int J Vitam Nutr Res 72: 77-84.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-75.
24. McGahon BM, Martin DS, Horrobin DF, Lynch MA. (1999). Agerelated changes in synaptic function: Analysis of the effect of dietary supplementation with omega-3 fatty acids. J Neurosci 94: 305-14.
25. Mena MA, Casarejos MJ, Carazo A, et al. (1997). Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms. J Neural Transm 104: 317-28.
26. Montine TJ, Neely MD, Quinn JF, et al. (2002). Lipid peroxidation in aging brain and Alzheimer's disease. J Free Radic Biol Med 33: 620-6.
27. Mori TA, Woodman RJ, Burke V, et al. (2003). Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 35: 772-81.
28. Nourooz-Zadeh J, Liu EH, Yhlen B, et al. (1999). F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J Neurochem 72: 734-40.
29. Oyanagui Y. (1984). Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem 142: 290-6.
30. Peng S, Zhang Y, Zhang JN, et al. (2010). ERK in learning and memory: A review of recent research. Int J Mol Sci 11: 222-32.
31. Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH. (2010). Neurotrophic factor therapy for Parkinson's disease. Progr Brain Res 184: 237-64.
32. Scott Bitner R. (2012). Cyclic AMP response element-binding protein (CREB) phosphorylation: A mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics. Biochem Pharmaco 83: 705-14.
33. Song JH, Miyazawa T. (2001). Enhanced level of n-3 fatty acid in membrane phospholipids induces lipid peroxidation in rats fed dietary docosahexaenoic acid oil. Atherosclerosis 155: 9-18.
34. Songur A, Sarsilmaz M, Sogut S, et al. (2004). Hypothalamic superoxide dismutase, xanthine oxidase, nitric oxide, and malondialdehyde in rats fed with fish !-3 fatty acids. Progr Neuropsychopharmacol Biol Psychiatry 28: 693-8.
35. Tabner BJ, Turnbull S, El-Agnaf O, Allsop D. (2001). Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr Top Med Chem 6: 507-17.
36. Tanriover G, Seval-Celik Y, Ozsoy O, et al. (2010). The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease. Folia Histochem Cytobiol 48: 434-41.
37. Tansey MG, Baloh RH, Milbrandt J, Johnson Jr EM. (2000). GFRamediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation and neuronal survival. Neuron 25: 611-23.
38. Treanor JJ, Goodman L, de Sauvage F, et al. (1996). Characterization of a multicomponent receptor for GDNF. Nature 382: 80-3.
39. Wu A, Ying Z, Gomez-Pinilla F. (2004). Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 21: 1457-67.